Patients With Multiple Myeloma Treated With Thalidomide: Evaluation of Clinical Parameters, Cytokines, Angiogenic Markers, Mast Cells and Marrow CD57+ Cytotoxic T Cells as Predictors of Outcome
Haematologica - Italy
doi 10.3324/haematol.11208
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 1, 2007
Authors
Publisher
Ferrata Storti Foundation (Haematologica)